Atlas Trials

Single-Dose PK Study of GBT440 in Subjects With Renal Impairment

Clinical trial NCT03161015 · COMPLETED

Trial details

NCT number
NCT03161015
Sponsor
Global Blood Therapeutics
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Renal Impairment
Start date
2016-11-01
Primary completion
2017-05-25
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.